ScienceDex / Researcher record
Wenliang Li
- UT Health Science Center Houston · Internal Medicine (NIH department code)
- Houston Methodist Research Institute (no department on record)
From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.
Start from a Word CV, PubMed IDs or ORCID.
Not you? Find your own page- R01 Holder
- Early Career
NIH Funding · FY2026
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2024 | $339,008 | 1 | #39,397 |
| 2025 | $356,850 | 1 | #39,306 |
| 2026 | $1,382,928 | 3 | #14,908 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20241 record
- FY20251 record
- FY2026 · selected3 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Citation measures
From ScienceDex publication records as of October 14, 2026. Google Scholar and Scopus count other sources, so their numbers differ.
Each number opens a page that explains the measure and compares researchers on it.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 11374471Search this ID in NIH RePORTER
- ORCID iD
- https://orcid.org/0000-0001-9452-4347Verified identifier for this researcher
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Internal Medicine
FY2026 award records by amount
NIH award records listing Wenliang Li as a PI. Multi-PI records show the full award amount for context.
- 1R01CA315906-01R01Contact PIThe role of GRK3-HDAC2 epigenetic pathway in neuroendocrine prostate cancer and immune evasion$514.9Kaward amount
- 1R01CA317755-01R01Contact PIMechanistic role of GPR6 in therapy resistance and its antibody-based targeting in prostate cancer$511.2Kaward amount
- 5R01CA270096-05R01Contact PIDissecting and targeting a novel vulnerability in aggressive Rb1 and p53 doubly deficient prostate cancerUT Health Science Center Houston · Internal Medicine (NIH department code)$356.9Kaward amount
Award organizations
Organizations that administered FY2026 awards listing Wenliang Li as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardHouston Methodist Research Institute
- 2025$500K Cumulative Funding
- 2025Multi-Institutional ResearchAwards at 2 institutions
- 2025R01 Grant Holder
- 2026$1M Cumulative Funding
- 2026$2M Cumulative Funding